Letters
Volume 28—2022
Volume 28, Number 12—December 2022
Hand, Foot, and Mouth Disease as Differential Diagnosis of Monkeypox, Germany, August 2022 [PDF - 493 KB - 1 page]
| EID | Fathi A, Schmiedel S. Hand, Foot, and Mouth Disease as Differential Diagnosis of Monkeypox, Germany, August 2022. Emerg Infect Dis. 2022;28(12):2586. https://doi.org/10.3201/eid2812.221487 |
|---|---|
| AMA | Fathi A, Schmiedel S. Hand, Foot, and Mouth Disease as Differential Diagnosis of Monkeypox, Germany, August 2022. Emerging Infectious Diseases. 2022;28(12):2586. doi:10.3201/eid2812.221487. |
| APA | Fathi, A., & Schmiedel, S. (2022). Hand, Foot, and Mouth Disease as Differential Diagnosis of Monkeypox, Germany, August 2022. Emerging Infectious Diseases, 28(12), 2586. https://doi.org/10.3201/eid2812.221487. |
Volume 28, Number 8—August 2022
Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance [PDF - 233 KB - 2 pages]
| EID | Freitas A, Pezzi L, Cavalcanti L, Simon F. Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance. Emerg Infect Dis. 2022;28(8):1736-1737. https://doi.org/10.3201/eid2808.220558 |
|---|---|
| AMA | Freitas A, Pezzi L, Cavalcanti L, et al. Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance. Emerging Infectious Diseases. 2022;28(8):1736-1737. doi:10.3201/eid2808.220558. |
| APA | Freitas, A., Pezzi, L., Cavalcanti, L., & Simon, F. (2022). Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance. Emerging Infectious Diseases, 28(8), 1736-1737. https://doi.org/10.3201/eid2808.220558. |
Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response) [PDF - 236 KB - 2 pages]
| EID | Anzinger JJ. Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response). Emerg Infect Dis. 2022;28(8):1737-1738. https://doi.org/10.3201/eid2808.221006 |
|---|---|
| AMA | Anzinger JJ. Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response). Emerging Infectious Diseases. 2022;28(8):1737-1738. doi:10.3201/eid2808.221006. |
| APA | Anzinger, J. J. (2022). Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response). Emerging Infectious Diseases, 28(8), 1737-1738. https://doi.org/10.3201/eid2808.221006. |
Imported Monkeypox from International Traveler, Maryland, USA, 2021 [PDF - 227 KB - 1 page]
| EID | Minhaj FS, Rao AK, McCollum AM. Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerg Infect Dis. 2022;28(8):1738. https://doi.org/10.3201/eid2808.220726 |
|---|---|
| AMA | Minhaj FS, Rao AK, McCollum AM. Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerging Infectious Diseases. 2022;28(8):1738. doi:10.3201/eid2808.220726. |
| APA | Minhaj, F. S., Rao, A. K., & McCollum, A. M. (2022). Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerging Infectious Diseases, 28(8), 1738. https://doi.org/10.3201/eid2808.220726. |
Imported Monkeypox from International Traveler, Maryland, USA, 2021 (Response) [PDF - 208 KB - 1 page]
| EID | Costello V, Sowash M, Gaur A, Cardis M, Pasieka H, Wortmann G, et al. Imported Monkeypox from International Traveler, Maryland, USA, 2021 (Response). Emerg Infect Dis. 2022;28(8):1739. https://doi.org/10.3201/eid2808.220830 |
|---|---|
| AMA | Costello V, Sowash M, Gaur A, et al. Imported Monkeypox from International Traveler, Maryland, USA, 2021 (Response). Emerging Infectious Diseases. 2022;28(8):1739. doi:10.3201/eid2808.220830. |
| APA | Costello, V., Sowash, M., Gaur, A., Cardis, M., Pasieka, H., Wortmann, G....Ramdeen, S. (2022). Imported Monkeypox from International Traveler, Maryland, USA, 2021 (Response). Emerging Infectious Diseases, 28(8), 1739. https://doi.org/10.3201/eid2808.220830. |
Volume 28, Number 6—June 2022
Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020 [PDF - 510 KB - 2 pages]
| EID | McNamara KX, Perz JF, Perkins KM. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020. Emerg Infect Dis. 2022;28(6):1303. https://doi.org/10.3201/eid2806.220520 |
|---|---|
| AMA | McNamara KX, Perz JF, Perkins KM. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020. Emerging Infectious Diseases. 2022;28(6):1303. doi:10.3201/eid2806.220520. |
| APA | McNamara, K. X., Perz, J. F., & Perkins, K. M. (2022). Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020. Emerging Infectious Diseases, 28(6), 1303. https://doi.org/10.3201/eid2806.220520. |
Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response) [PDF - 510 KB - 2 pages]
| EID | Daniau C, Berger-Carbonne A, Cambau E. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response). Emerg Infect Dis. 2022;28(6):1303-1304. https://doi.org/10.3201/eid2806.220686 |
|---|---|
| AMA | Daniau C, Berger-Carbonne A, Cambau E. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response). Emerging Infectious Diseases. 2022;28(6):1303-1304. doi:10.3201/eid2806.220686. |
| APA | Daniau, C., Berger-Carbonne, A., & Cambau, E. (2022). Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response). Emerging Infectious Diseases, 28(6), 1303-1304. https://doi.org/10.3201/eid2806.220686. |
Volume 28, Number 5—May 2022
Guillain-Barré Syndrome Associated with COVID-19 Vaccination [PDF - 237 KB - 2 pages]
| EID | Finsterer J, Scorza FA, Scorza CA. Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerg Infect Dis. 2022;28(5):1079-1080. https://doi.org/10.3201/eid2805.212145 |
|---|---|
| AMA | Finsterer J, Scorza FA, Scorza CA. Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerging Infectious Diseases. 2022;28(5):1079-1080. doi:10.3201/eid2805.212145. |
| APA | Finsterer, J., Scorza, F. A., & Scorza, C. A. (2022). Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerging Infectious Diseases, 28(5), 1079-1080. https://doi.org/10.3201/eid2805.212145. |
SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia [PDF - 237 KB - 2 pages]
| EID | Grassia JT, Markwalter CF, O’Meara WP, Taylor SM, Obala AA. SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerg Infect Dis. 2022;28(5):1080-1081. https://doi.org/10.3201/eid2805.220404 |
|---|---|
| AMA | Grassia JT, Markwalter CF, O’Meara WP, et al. SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerging Infectious Diseases. 2022;28(5):1080-1081. doi:10.3201/eid2805.220404. |
| APA | Grassia, J. T., Markwalter, C. F., O’Meara, W. P., Taylor, S. M., & Obala, A. A. (2022). SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerging Infectious Diseases, 28(5), 1080-1081. https://doi.org/10.3201/eid2805.220404. |
Melioidosis in Children, Brazil, 1989–2019 [PDF - 237 KB - 2 pages]
| EID | Behera B, Radhakrishnan A, Mohapatra S, Mishra B. Melioidosis in Children, Brazil, 1989–2019. Emerg Infect Dis. 2022;28(5):1081-1082. https://doi.org/10.3201/eid2805.211473 |
|---|---|
| AMA | Behera B, Radhakrishnan A, Mohapatra S, et al. Melioidosis in Children, Brazil, 1989–2019. Emerging Infectious Diseases. 2022;28(5):1081-1082. doi:10.3201/eid2805.211473. |
| APA | Behera, B., Radhakrishnan, A., Mohapatra, S., & Mishra, B. (2022). Melioidosis in Children, Brazil, 1989–2019. Emerging Infectious Diseases, 28(5), 1081-1082. https://doi.org/10.3201/eid2805.211473. |
Melioidosis in Children, Brazil, 1989–2019 (response) [PDF - 212 KB - 1 page]
| EID | Lima R, Rolim D. Melioidosis in Children, Brazil, 1989–2019 (response). Emerg Infect Dis. 2022;28(5):1081-1082. https://doi.org/10.3201/eid2805.220479 |
|---|---|
| AMA | Lima R, Rolim D. Melioidosis in Children, Brazil, 1989–2019 (response). Emerging Infectious Diseases. 2022;28(5):1081-1082. doi:10.3201/eid2805.220479. |
| APA | Lima, R., & Rolim, D. (2022). Melioidosis in Children, Brazil, 1989–2019 (response). Emerging Infectious Diseases, 28(5), 1081-1082. https://doi.org/10.3201/eid2805.220479. |
High-Dose Convalescent Plasma for Treatment of Severe COVID-19 [PDF - 197 KB - 1 page]
| EID | Focosi D, Casadevall A. High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerg Infect Dis. 2022;28(5):1083. https://doi.org/10.3201/eid2805.220191 |
|---|---|
| AMA | Focosi D, Casadevall A. High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerging Infectious Diseases. 2022;28(5):1083. doi:10.3201/eid2805.220191. |
| APA | Focosi, D., & Casadevall, A. (2022). High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerging Infectious Diseases, 28(5), 1083. https://doi.org/10.3201/eid2805.220191. |
High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response) [PDF - 206 KB - 2 pages]
| EID | De Santis GC, Calado RT. High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerg Infect Dis. 2022;28(5):1083-1084. https://doi.org/10.3201/eid2805.220363 |
|---|---|
| AMA | De Santis GC, Calado RT. High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerging Infectious Diseases. 2022;28(5):1083-1084. doi:10.3201/eid2805.220363. |
| APA | De Santis, G. C., & Calado, R. T. (2022). High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerging Infectious Diseases, 28(5), 1083-1084. https://doi.org/10.3201/eid2805.220363. |
Volume 28, Number 3—March 2022
Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level [PDF - 691 KB - 1 page]
| EID | Barr IG, Williams TC, Salimi V, Buchholz UJ. Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerg Infect Dis. 2022;28(3):764. https://doi.org/10.3201/eid2803.212438 |
|---|---|
| AMA | Barr IG, Williams TC, Salimi V, et al. Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerging Infectious Diseases. 2022;28(3):764. doi:10.3201/eid2803.212438. |
| APA | Barr, I. G., Williams, T. C., Salimi, V., & Buchholz, U. J. (2022). Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerging Infectious Diseases, 28(3), 764. https://doi.org/10.3201/eid2803.212438. |
Volume 28, Number 2—February 2022
High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh [PDF - 1.01 MB - 2 pages]
| EID | Hegde ST, Bhuiyan T, Akhtar M, Islam T, Hulse J, Khan Z, et al. High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh. Emerg Infect Dis. 2022;28(2):491-492. https://doi.org/10.3201/eid2802.212417 |
|---|---|
| AMA | Hegde ST, Bhuiyan T, Akhtar M, et al. High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh. Emerging Infectious Diseases. 2022;28(2):491-492. doi:10.3201/eid2802.212417. |
| APA | Hegde, S. T., Bhuiyan, T., Akhtar, M., Islam, T., Hulse, J., Khan, Z....Qadri, F. (2022). High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh. Emerging Infectious Diseases, 28(2), 491-492. https://doi.org/10.3201/eid2802.212417. |
Predictors of Nonseroconversion after SARS-CoV-2 Infection [PDF - 618 KB - 2 pages]
| EID | Davido B, Jaffal K, Annane D, Lawrence C, Gault E, De P. Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerg Infect Dis. 2022;28(2):492-493. https://doi.org/10.3201/eid2802.211971 |
|---|---|
| AMA | Davido B, Jaffal K, Annane D, et al. Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerging Infectious Diseases. 2022;28(2):492-493. doi:10.3201/eid2802.211971. |
| APA | Davido, B., Jaffal, K., Annane, D., Lawrence, C., Gault, E., & De, P. (2022). Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerging Infectious Diseases, 28(2), 492-493. https://doi.org/10.3201/eid2802.211971. |
Volume 28, Number 1—January 2022
New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria [PDF - 653 KB - 1 page]
| EID | Yao Y, Imirzalioglu C, Falgenhauer L, Chakraborty T. New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria. Emerg Infect Dis. 2022;28(1):265. https://doi.org/10.3201/eid2801.212106 |
|---|---|
| AMA | Yao Y, Imirzalioglu C, Falgenhauer L, et al. New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria. Emerging Infectious Diseases. 2022;28(1):265. doi:10.3201/eid2801.212106. |
| APA | Yao, Y., Imirzalioglu, C., Falgenhauer, L., & Chakraborty, T. (2022). New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria. Emerging Infectious Diseases, 28(1), 265. https://doi.org/10.3201/eid2801.212106. |
Page created: December 03, 2021
Page updated: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
